Zobrazeno 1 - 10
of 17
pro vyhledávání: '"G V Upton"'
Publikováno v:
Human Psychopharmacology: Clinical and Experimental. 10:195-200
A meta-analysis was performed to assess the effectiveness of the novel antidepressant venlafaxine in depressed patients with psychomotor retardation and/or agitation [respective baseline item score greater than zero on the Hamilton Rating Scale for D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad20aa75dc88742277997dd92ea9efec
https://doi.org/10.1002/hup.470100305
https://doi.org/10.1002/hup.470100305
Publikováno v:
Obstetrics and gynecology. 98(5 Pt 1)
To evaluate the efficacy and safety of venlafaxine, a new-generation antidepressant that selectively inhibits serotonin and norepinephrine reuptake, in the treatment of premenstrual dysphoric disorder (PMDD).We conducted a randomized, double-blind, p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fc7cff4c9d3687044c3afff3af4ba292
https://pubmed.ncbi.nlm.nih.gov/11704162
https://pubmed.ncbi.nlm.nih.gov/11704162
Publikováno v:
Journal of clinical psychopharmacology. 18(1)
This 12-week, double-blind, placebo-controlled study evaluated the efficacy and safety of venlafaxine as first-line therapy for the treatment of major depression and major depression associated with anxiety in 384 adult outpatients. Fixed total daily
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::21381e5e3d28d64f56adcf26352e3356
https://pubmed.ncbi.nlm.nih.gov/9472838
https://pubmed.ncbi.nlm.nih.gov/9472838
Publikováno v:
Clinical obstetrics and gynecology. 35(4)
Many women older than 40 years of age require both contraceptive protection and hormonal replacement therapy for climacteric symptoms. Combination therapy is advisable but progestins should be added to estrogen to prevent endometrial hyperplasia, dec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dbb7c7faa84b339df31f2640e480e37
https://pubmed.ncbi.nlm.nih.gov/1451368
https://pubmed.ncbi.nlm.nih.gov/1451368
Autor:
G V, Upton
Publikováno v:
The Journal of reproductive medicine. 27(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0f6da57d5746492fd40341012e421bcc
https://pubmed.ncbi.nlm.nih.gov/7047734
https://pubmed.ncbi.nlm.nih.gov/7047734
Autor:
G V, Upton
Publikováno v:
The Journal of reproductive medicine. 26(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d134665d8cf93d58a30b62f6c653a957
https://pubmed.ncbi.nlm.nih.gov/7031238
https://pubmed.ncbi.nlm.nih.gov/7031238
Autor:
G V, Upton
Publikováno v:
International journal of fertility. 30(4)
There is a growing awareness that many women over 40 require both contraceptive protection and hormonal replacement for the symptoms of the climacteric. These women are still menstruating and the risk of pregnancy remains, overshadowed by the increas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4864b17e58f584323e4f4e8364d7bc4c
https://pubmed.ncbi.nlm.nih.gov/2890595
https://pubmed.ncbi.nlm.nih.gov/2890595
Autor:
G V, Upton
Publikováno v:
The Journal of reproductive medicine. 29(2)
The natural aging process affects a woman greatly during the climacteric; hormonal patterns, metabolic parameters, reproductive target organs and bone are involved. In every instance one can compare these changes with the effects of hormone-replaceme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::da23dab814f1ccf98889a1288cb5c651
https://pubmed.ncbi.nlm.nih.gov/6368816
https://pubmed.ncbi.nlm.nih.gov/6368816
Publikováno v:
The New England journal of medicine. 292(11)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3ba3559f52ed4af75161151e5ccf8bc9
https://pubmed.ncbi.nlm.nih.gov/1110678
https://pubmed.ncbi.nlm.nih.gov/1110678
Autor:
G V, Upton
Publikováno v:
Obstetrics and gynecology clinics of North America. 14(1)
All the existing data show that combination estrogen/progestogen therapy is mandatory if any replacement therapy is to be given to the woman over age 40. Sufficient evidence has indicated that estrogen alone is inadequate; progestogen must be given t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::182eb705c62cf3a2639c835236b76533
https://pubmed.ncbi.nlm.nih.gov/3306520
https://pubmed.ncbi.nlm.nih.gov/3306520